LFMD vs. AUNA, MODV, ACB, ANRO, TERN, ANIK, CERS, ORGO, SLDB, and AMRN
Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Auna (AUNA), ModivCare (MODV), Aurora Cannabis (ACB), Alto Neuroscience (ANRO), Terns Pharmaceuticals (TERN), Anika Therapeutics (ANIK), Cerus (CERS), Organogenesis (ORGO), Solid Biosciences (SLDB), and Amarin (AMRN). These companies are all part of the "medical" sector.
LifeMD (NASDAQ:LFMD) and Auna (NYSE:AUNA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.
LifeMD received 23 more outperform votes than Auna when rated by MarketBeat users. However, 100.00% of users gave Auna an outperform vote while only 71.05% of users gave LifeMD an outperform vote.
In the previous week, Auna had 7 more articles in the media than LifeMD. MarketBeat recorded 11 mentions for Auna and 4 mentions for LifeMD. LifeMD's average media sentiment score of 0.50 beat Auna's score of 0.26 indicating that LifeMD is being referred to more favorably in the media.
Auna has lower revenue, but higher earnings than LifeMD.
Auna has a net margin of 0.00% compared to LifeMD's net margin of -14.75%.
LifeMD currently has a consensus target price of $12.60, indicating a potential upside of 63.42%. Auna has a consensus target price of $14.15, indicating a potential upside of 71.52%. Given Auna's higher possible upside, analysts plainly believe Auna is more favorable than LifeMD.
35.5% of LifeMD shares are held by institutional investors. 18.9% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
LifeMD beats Auna on 6 of the 11 factors compared between the two stocks.
Get LifeMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
